Volume 14 Supplement 6

Viral Hepatitis and Drug Use in Europe

Research and Commentaries

Edited by Jeffrey V Lazarus and Kevin A Fenton

This publication has been produced with the financial support of the Drug Prevention and Information Programme (DPIP) of the European Union. The contents of this publication are the sole responsibility of the authors and can in no way be taken to reflect the view of the European Commission. The publication charges for this supplement were funded by AbbVie as an unresitricted grant to Rigshospitalet, the University of Copenhagen, Denmark. AbbVie further co-funded the printing of the supplement. The peer review process was overseen by the Supplement Editors in accordance with BioMed Central's peer review guidelines for supplements. The Supplement Editors declare that they have no competing interests.

 Read the blog related to this supplement.

  1. Research

    Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities

    Behavioural surveillance among people who inject drugs (PWID) and testing for hepatitis C virus (HCV) and HIV is needed to understand the scope of both epidemics in at-risk populations and to suggest steps to ...

    Robert Heimer, Ksenia Eritsyan, Russell Barbour and Olga S Levina

    BMC Infectious Diseases 2014 14(Suppl 6):S12

    Published on: 19 September 2014

  2. Research

    Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries

    Hepatitis C virus (HCV) infection represents a major global health problem, which in high-income countries now mostly affects people who inject drugs (PWID). Many studies show that the treatment of HCV infecti...

    Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz and Jeffrey V Lazarus

    BMC Infectious Diseases 2014 14(Suppl 6):S14

    Published on: 19 September 2014

  3. Research

    Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey

    Unsafe injections, through infectious bodily fluids, are a major route of transmission for hepatitis B and C. Viral hepatitis burden among people who inject drugs is particularly high in many Member States of ...

    Alexander Spina, Irina Eramova and Jeffrey V Lazarus

    BMC Infectious Diseases 2014 14(Suppl 6):S15

    Published on: 19 September 2014

  4. Review

    Hepatitis C in European prisons: a call for an evidence-informed response

    Globally, over 10 million people are held in prisons and other places of detention at any given time. People who inject drugs (PWID) comprise 10-48% of male and 30-60% of female prisoners. The spread of hepati...

    Amber Arain, Geert Robaeys and Heino Stöver

    BMC Infectious Diseases 2014 14(Suppl 6):S17

    Published on: 19 September 2014